Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549

doi:10.16352/j.issn.1001-6325.2024.07.0974

Abstract

Abstract: Objective To investigate the effect of inhibiting the expression of RNA component of mitochondrial RNA processing endoribonuclease(RMRP) on the proliferation and invasion of human lung cancer cell line A549 in order to provide evidence to support the research on NSCLC mechanism. Methods A total of 122 cases of patients who underwent surgical treatment were selected in Jiaozuo People′s Hospital from March 2016 to March 2021. In the same period, 50 healthy people from physical examination center were selected as the control group. RT-qPCR was used to detect the expressions of RMRP in blood and tissues. Human lung cancer cell line A549 was cultured and divided into si-RMRP group, siRNA-NC group and blank group.RT-qPCR, CCK-8 and Transwell assays were used to detect the expression of RMRP, proliferation activity and cell counting of invasive cells. Results The relative expression level of RMRP in the blood of NSCLC patients was significantly higher than that of control group (P＜0.001). The relative expression level of RMRP in NSCLC tissues was significantly higher than the adjacent tissues (P＜0.001). The relative expression level of RMRP in blood and tissues of patients with poorly differentiated, lymph node metastasis and TNM stage Ⅲ compared with moderate to highly differentiated, no lymph node metastasis and TNM stage Ⅰ-Ⅱ were significantly increased (P＜0.05). The relative expression level of RMRP in the cells of the si-RMRP group was lower than that of blank and the siRNA-NC group (P＜0.001). Compared with the blank group and the siRNA-NC group, the absorbance (A) value of cells at 24, 48, 72 and 96 h in the si-RMRP group was decreased (P＜0.05). The number of invasion cells in the si-RMRP group was lower than that in the blank group and the siRNA-NC group (F=27.765, P＜0.001). Conclusions The relative expression levels of RMRP in blood and tissues of NSCLC patients are increased. Down-regulation of the expression of RMRP gene in A549 cells can inhibit cell proliferation and reduce cell invasion.

Key words: non-small cell lung cancer, long non-coding RNA(lnRNA), RNA component of mitochondrial RNA processing endoribonuclease(RMRP), proliferation, invasion

CLC Number:

R734.2

ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan. Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549[J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.

References

[1]赫捷, 李霓, 陈万青, 等. 中国肺癌筛查与早诊早治指南(2021,北京)[J], 中国肿瘤, 2021, 30:81-111.
[2]张小婉, 康霞, 姚小英, 等. 沉默SF3B1促进人肺癌细胞系A549凋亡并抑制其增殖及侵袭[J]. 基础医学与临床, 2023, 43:1265-1270.
[3]高媛, 周妍, 周新佳, 等. 白细胞介素-9及其受体在非小细胞肺癌组织中的表达及临床意义[J]. 中国医科大学学报, 2021, 50:511-515.
[4]Ginn L, Shi L, Montagna M, et al. LncRNAs in non-small-cell lung cancer[J]. Noncoding RNA, 2020, 6:25-49.
[5]Li C, Lv Y, Shao C, et al. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis[J]. J Cell Physiol, 2019, 234:20721-20727.
[6]Cao HL, Liu ZJ, Huang PL, et al. LncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206[J]. Eur Rev Med Pharmacol Sci, 2019, 23:1012-1021.
[7]Suster DI, Mino-Kenudson M. Molecular pathology of primary non-small cell lung cancer[J]. Arch Med Res, 2020, 51:784-798.
[8]杨晔, 党荣广, 张静, 等. 肺癌组织中lncRNA ZFAS1和hsa-miR-372-3p的表达与患者恶性特征及预后的关系[J]. 基础医学与临床, 2022, 42:1861-1866.
[9]秦维超, 张琳. 非小细胞肺癌组织miR-25表达变化及其临床意义[J]. 山东医药, 2020, 60:63-65,87.
[10]许娟, 蔡长青, 李玉婵, 等. 长链非编码RNA在非小细胞肺癌诊断中的研究进展[J]. 海南医学, 2020, 31:1867-1871.
[11]周善学, 朱春霞, 陆蓉丹, 等. 胃液长链非编码 RNA RMRP的检测及其临床价值分析[J]. 浙江医学, 2018, 40:134-137,141.
[12]Cao HL, Liu ZJ, Huang PL, et al. LncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206[J]. Eur Rev Med Pharmacol Sci, 2019, 23:1012-1021.
[13]Ghanizade P, Oroujalian A, Peymani M. Differential expression analysis of CCDC107 and RMRP lncRNA as potential biomarkers in colorectal cancer diagnosis[J]. Nucleos Nucleot Nucl, 2021, 40:1144-1158.
[14]Xie Z, Liu S, Chu S, et al. LncRNA RMRP predicts poor prognosis and mediates tumor progression of esophageal squamous cell carcinoma by regulating miR-613/neuro-pilin 2 (NRP2) axis[J]. Bioengineered, 2021, 12:6913-6922.

[1]	CAO Qingwen, QI Lin, YU Bo, TIAN Chenchen, YUAN Haining, WANG Yue. Salidroside promotes proliferation and migration of human vascular endothelial cell line EA.hy926 [J]. Basic & Clinical Medicine, 2024, 44(7): 925-930.
[2]	ZHANG Pengju, LI Jie, ZHANG Mengdi, SUN Shaoke, XU Yinzhe. KAT8 promotes the proliferation of colorectal cancer cell lines by enhancing METTL3 expression [J]. Basic & Clinical Medicine, 2024, 44(7): 931-939.
[3]	GAO Yinjie, TONG Anli. Mechanisms of cell death and proliferation of aldosterone-producing adenoma [J]. Basic & Clinical Medicine, 2024, 44(6): 758-762.
[4]	WANG Tingting, XIAO Ning, LIN Dianxin, DONG Haitao. Allicin inhibits the proliferation of oral cancer cells line CAL27 [J]. Basic & Clinical Medicine, 2024, 44(5): 673-676.
[5]	JIA Anna, GUO Jinxin, ZHANG Xuan, ZHAN Shijia, YU Yongbo, GUO Yongli, CHANG Yan. Regulation of TMEFF1 on proliferation of neuroblastoma cell lines [J]. Basic & Clinical Medicine, 2024, 44(5): 637-644.
[6]	LIANG Xiangcun, WEI Xiaoyu, LIANG Jian, WANG Qing, GENG Guang. Anlotinib inhibits proliferation and promotes apoptosis of human non-small cell lung cancer cell lines through miR-16-5p/PD-1 axis [J]. Basic & Clinical Medicine, 2024, 44(4): 503-512.
[7]	LU Kai, LU Jianju, GUO Wenli, HUANG Jianqi, LI Zhihua. lncRNA VIM-AS5 expression and its effect on proliferation and migration of human breast cancer cell lines [J]. Basic & Clinical Medicine, 2024, 44(4): 447-453.
[8]	GUO Hongjiang, XU Yeting, ZHANG Diya, QIU Jiaxing, WANG Yucheng, JU Rui, GUO Lei. Effect of carboxyamidotriazole-orotate on proliferation and fatty acid anabolism of human pancreatic cancer cell lines [J]. Basic & Clinical Medicine, 2024, 44(4): 440-446.
[9]	LI Na, LI Tao, YANG Dongli, YAO Yuan. Honokiol inhibits the proliferation of human adipose-derived mesenchymal stem cells [J]. Basic & Clinical Medicine, 2024, 44(4): 483-488.
[10]	ZHANG Jing, YANG Zigeng, CAI Wenqin, CAO Weiwei, WEI Hongmei, XUE Xixi, WU Bin. Inhibition of prohibitin 2 enhances the sensitivity of non-small cell lung cancer cell line A549 to erlotinib [J]. Basic & Clinical Medicine, 2024, 44(3): 325-332.
[11]	AN Qi, QI Guangzhao, HAN Chao. Aucubin inhibits the proliferation of human hepatocellular carcinoma cells line HepG2 [J]. Basic & Clinical Medicine, 2024, 44(3): 333-338.
[12]	JIA Anna, ZHAN Shijia, ZHANG Xuan, GUO Jinxin, YU Yongbo, GUO Yongli, CHANG Yan. Regulatory effect of C12ORF66 on viability of MYCN amplified high-risk neuroblastoma cells [J]. Basic & Clinical Medicine, 2024, 44(3): 288-294.
[13]	LI Juan, LI Xiaofeng, XU Shengzhi, TANG Kai. Efficacy of cinobufacini capsule combined with docetaxel plus cisplatin chemotherapy for the treatment of non-small cell lung cancer [J]. Basic & Clinical Medicine, 2024, 44(2): 247-251.
[14]	FANG Yuan, LI Yi, WANG Wei. CircRERE promotes proliferation, migration and invasion of human multiple myeloma cell lines by regulating miR-128-3p/WEE1 axis [J]. Basic & Clinical Medicine, 2024, 44(2): 210-218.
[15]	DING Fei, WANG Sa, HUANG Changxin. Serum CA211 level and NK cell number are associated with prognosis of patients with non-small cell lung cancer [J]. Basic & Clinical Medicine, 2024, 44(2): 180-184.